Lapalombella, R., Andritsos, L., Liu, Q., May, S. E., Browning, R., Pham, L. V., . . . Byrd, J. C. (2010). Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase–dependent pathway. American Society of Hematology.
Citação norma ChicagoLapalombella, Rosa, et al. Lenalidomide Treatment Promotes CD154 Expression On CLL Cells and Enhances Production of Antibodies By Normal B Cells Through a PI3-kinase–dependent Pathway. American Society of Hematology, 2010.
Citação norma MLALapalombella, Rosa, et al. Lenalidomide Treatment Promotes CD154 Expression On CLL Cells and Enhances Production of Antibodies By Normal B Cells Through a PI3-kinase–dependent Pathway. American Society of Hematology, 2010.